Barclays’s FT Vest US Equity Enhance & Moderate Buffer ETF March XMAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$202K Sell
4,997
-10
-0.2% -$402 ﹤0.01% 3677
2025
Q4
$200K Sell
5,007
-602
-11% -$23.8K ﹤0.01% 4315
2025
Q3
$220K Sell
5,609
-156
-3% -$6.05K ﹤0.01% 4249
2025
Q2
$221K Buy
5,765
+1,775
+44% +$65.7K ﹤0.01% 4213
2025
Q1
$147K Sell
3,990
-1,536
-28% -$56.2K ﹤0.01% 4216
2024
Q4
$200K Buy
5,526
+1,160
+27% +$41.6K ﹤0.01% 4310
2024
Q3
$155K Buy
+4,366
New +$152K ﹤0.01% 4421

Other funds holding XMAR

Barclays's XMAR Position: Q1 2026 in Review

Barclays reduced its FT Vest US Equity Enhance & Moderate Buffer ETF March (XMAR) stake by 0.2% in Q1 2026, selling an estimated $402 and leaving 4,997 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #3677.

Barclays first reported a position in XMAR in Q3 2024 and has held it in 7 quarters since. The position peaked at $221K in Q2 2025. 69 funds tracked by Wall St. Rank hold XMAR as of Q1 2026.

  • Barclays held 4,997 shares of FT Vest US Equity Enhance & Moderate Buffer ETF March worth $202K as of Q1 2026.
  • Barclays sold 10 FT Vest US Equity Enhance & Moderate Buffer ETF March shares in Q1 2026, an estimated $402.
  • FT Vest US Equity Enhance & Moderate Buffer ETF March made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3677 holding.
  • Barclays first reported a position in FT Vest US Equity Enhance & Moderate Buffer ETF March in Q3 2024 and has held it in 7 quarters since.
  • Barclays's FT Vest US Equity Enhance & Moderate Buffer ETF March position peaked at $221K in Q2 2025.
  • 69 funds tracked by Wall St. Rank held FT Vest US Equity Enhance & Moderate Buffer ETF March as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.